These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. The influence of antihypertensive drugs on mineral status in hypertensive patients. Suliburska J; Bogdanski P; Szulinska M; Pupek-Musialik D Eur Rev Med Pharmacol Sci; 2014; 18(1):58-65. PubMed ID: 24452943 [TBL] [Abstract][Full Text] [Related]
4. Diuretics, Ca-Antagonists, and Angiotensin-Converting Enzyme Inhibitors Affect Zinc Status in Hypertensive Patients on Monotherapy: A Randomized Trial. Suliburska J; Skrypnik K; Szulińska M; Kupsz J; Markuszewski L; Bogdański P Nutrients; 2018 Sep; 10(9):. PubMed ID: 30208601 [TBL] [Abstract][Full Text] [Related]
5. [Assessment of the antihypertensive therapy with 24 ambulatory monitoring of blood pressure]. Sugai J; Mikawa T Nihon Rinsho; 1992 May; 50 Suppl():39-45. PubMed ID: 1355136 [No Abstract] [Full Text] [Related]
6. [Hypertension therapy in practice test. Calcium antagonist receives good marks]. Keck M; Sauerbrey-Wullkopf N; Regourd E; Clemens A MMW Fortschr Med; 2005 Jan; 147(1-2):51. PubMed ID: 15704573 [No Abstract] [Full Text] [Related]
7. [Renin-angiotensin-aldosterone system inhibition: pharmacologic rationale and evaluations of drug combinations]. Andréjak M; Slama M; Hary L Therapie; 1998; 53(3):291-300. PubMed ID: 9773129 [TBL] [Abstract][Full Text] [Related]
8. [How to use anti-hypertensive medication in management of diabetic patients]. Hirose H; Saito I Nihon Rinsho; 2003 Jul; 61(7):1205-9. PubMed ID: 12877086 [TBL] [Abstract][Full Text] [Related]
10. Description of antihypertensive use in patients with resistant hypertension prescribed four or more agents. Hanselin MR; Saseen JJ; Allen RR; Marrs JC; Nair KV Hypertension; 2011 Dec; 58(6):1008-13. PubMed ID: 22042809 [TBL] [Abstract][Full Text] [Related]
11. Development and trends in the drug treatment of essential hypertension. van Zwieten PA J Hypertens Suppl; 1992 Dec; 10(7):S1-12. PubMed ID: 1363322 [TBL] [Abstract][Full Text] [Related]
12. Factors related to the impact of antihypertensive treatment in antioxidant activities and oxidative stress by-products in human hypertension. Sáez GT; Tormos C; Giner V; Chaves J; Lozano JV; Iradi A; Redón J Am J Hypertens; 2004 Sep; 17(9):809-16. PubMed ID: 15363824 [TBL] [Abstract][Full Text] [Related]
13. [Selection and combined therapy of antihypertensive drugs]. Masuyama Y Nihon Rinsho; 1992 May; 50 Suppl():8-11. PubMed ID: 1355142 [No Abstract] [Full Text] [Related]
14. [Comparison of preventive effect of "new" and "old" antihypertensive agents]. Kjeldsen SE; Syvertsen JO; Lund-Johansen P; Hildebrandt P; Hansson L Tidsskr Nor Laegeforen; 2001 Apr; 121(11):1374-6. PubMed ID: 11419108 [TBL] [Abstract][Full Text] [Related]
15. Factors influencing hepatic metabolism of antihypertensive drugs: impact on clinical response. Höcht C; Bertera FM; Santander Plantamura Y; Parola L; Del Mauro JS; Polizio AH Expert Opin Drug Metab Toxicol; 2019 Jan; 15(1):1-13. PubMed ID: 30582386 [TBL] [Abstract][Full Text] [Related]
16. [Calcium antagonists: current and future applications based on new evidence. Combination antihypertensive therapy with calcium channel blockers]. Ishimitsu T Clin Calcium; 2010 Jan; 20(1):52-60. PubMed ID: 20048434 [TBL] [Abstract][Full Text] [Related]